Skip to content
Research Article Open access CC BY 4.0

External Beam Radiation Therapy in Mediastinal Metastasis of Radioiodine-Refractory Papillary Thyroid Carcinoma: A Case Report

Christine T.U. Banjarnahor, Matthew N. Ruslim

Journal of Cancer and Tumor International · pp. 82–88 · Published 11 Feb 2026

10.9734/jcti/2026/v16i1343

Abstract

External beam radiation therapy (EBRT) for mediastinal metastasis of papillary thyroid carcinoma is challenging because of the radioresistance of the cancer cells and surrounding vital organs. A 45 year-old male was diagnosed with mediastinal metastasis of refractory papillary thyroid carcinoma based on 18F-Fluordeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) scan results. He received EBRT with the Volumetric Modulated Arc Therapy (VMAT) technique that gave very satisfying results to prevent airway obstruction and improve his symptoms. The total radiation dose was 50 Gy in 25 fractions over five weeks. One year after radiation therapy, the evaluation showed a good local and clinical response with no late toxicities. This case presentation offers important evidence for EBRT on treating a high risk, unresectable and metastatic papillary thyroid carcinoma where conventional therapy was not successful to control tumor progression.

Mediastinal metastasis refractory papillary thyroid carcinoma EBRT VMAT

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.